MINNESOTA MEDICAL CANNABIS PROGRAM UPDATE MICHELLE LARSON, DIRECTOR - - PowerPoint PPT Presentation

minnesota medical cannabis program update
SMART_READER_LITE
LIVE PREVIEW

MINNESOTA MEDICAL CANNABIS PROGRAM UPDATE MICHELLE LARSON, DIRECTOR - - PowerPoint PPT Presentation

MINNESOTA MEDICAL CANNABIS PROGRAM UPDATE MICHELLE LARSON, DIRECTOR OFFICE OF MEDICAL CANNABIS JANUARY 12 TH , 2015 Registry Profiles general counts MN Medical Cannabis Registry Numbers 900 800 700 600 Number of People 500 400 300


slide-1
SLIDE 1

MINNESOTA MEDICAL CANNABIS PROGRAM UPDATE

MICHELLE LARSON, DIRECTOR OFFICE OF MEDICAL CANNABIS JANUARY 12TH , 2015

slide-2
SLIDE 2

Registry Profiles – general counts

As of 1/4/16

100 200 300 400 500 600 700 800 900 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Number of People

Week of Program

MN Medical Cannabis Registry Numbers HCPs Patients Caregivers

slide-3
SLIDE 3

Patients – age group profiles

Number Percent

  • Less than 18 yrs:

106 12.6%

  • 18 yrs to 30 yrs:

111 13.2%

  • 31 yrs to 50 yrs:

274 32.4%

  • 51 yrs to 70 yrs:

296 35%

  • 71 yrs and older:

57 6.8%

As of 1/4/16

slide-4
SLIDE 4

Patients – gender profile

Number Percent

  • Female:

360 42.6%

  • Male:

481 57.0%

  • No answer

3 .4%

As of 1/4/16

slide-5
SLIDE 5

Patients – Qualifying Medical Conditions

491 86 259 214 148 20 68 20 55 37 32 26 297 100 200 300 400 500 600 SEVERE AND PERSISTENT MUSCLE SPASMS, INCLUDING MS CROHN'S DISEASE CANCER-SEVERE OR CHRONIC PAIN CANCER-NAUSEA OR SEVERE VOMITING CANCER-CACHEXIA OR SEVERE WASTING TOURETTE SYNDROME HIV OR AIDS GLAUCOMA TERMINAL ILLNESS-SEVERE OR CHRONIC PAIN TERMINAL ILLNESS-NAUSEA OR SEVERE VOMITING TERMINAL ILLNESS-CACHEXIA OR SEVERE WASTING AMYOTROPHIC LATERAL SCLEROSIS (ALS) SEIZURES, INCLUDING THOSE CHARACTERISTIC OF EPILEPSY

Approved Patients by Condition

As of 1/4/16

slide-6
SLIDE 6

OMC Observational Research Update

  • Led by Tom Arneson, MD; Susan P. Anderson, PhD;

and Deepa McGriff, MPH

  • Research database
  • Much progress with development
  • Substantial testing and tweaking remains
  • Hope to have substantive results to report by end of March
  • Patient and health care practitioner surveys
  • Now underway – sent at 3 months
  • Response rate around 50% for patients and 35% for health care practitioners
slide-7
SLIDE 7

Other statutory requirements

  • Rulemaking:
  • Medical cannabis rules are in Minnesota Rules, Chapter 7440.
  • Rule amendments that were proposed through the formal statutory process will have a public

hearing on Friday, January 22, 2016.

  • Rulemaking advisory committee of stakeholders assisted
  • Published in State Register on November 16, 2015
  • Independent Laboratories:
  • Two have been approved by MDH
  • Continuous enrollment so could be more
slide-8
SLIDE 8

Intractable Pain

  • 12/2/15: MDH announced decision to add intractable pain as a

qualifying medical condition

  • 12/31/15: MDH notified Task Force co-chairs of decision
  • 1/15/16: MDH will notify legislators of the decision, as required

by Minn.Stat. §152.27, subd. 2(b)

  • 8/1/16:

effective date, unless legislature provides otherwise

slide-9
SLIDE 9

References and Resources

http://www.health.state.mn.us/topics/cannabis/